Last updated: February 20, 2026
What Does Patent AR124577 Cover?
Patent AR124577, granted by Argentina's National Institute of Industrial Property (INPI), pertains to a pharmaceutical compound or method of use, which falls within the country's patent classifications. The patent was filed with a priority date of 2019, granted in 2022, and classified under international patent classifications (IPC) relevant to pharmaceutical compositions and methods.
The patent dossier indicates claims directed toward a specific chemical entity and its method of use for treating particular diseases. The scope emphasizes the compound’s novel chemical structure and its pharmaceutical application, possibly covering formulations, dosage forms, and methods of delivery.
Key Claims Summary
| Claim Number |
Description |
Specificity |
Scope |
| Claim 1 |
A chemical compound with a defined structure. |
Broadest; defines the core molecule. |
Encompasses the compound itself. |
| Claim 2 |
A pharmaceutical composition comprising the compound. |
Includes formulations with carriers. |
Extended to formulations. |
| Claim 3 |
Use of the compound in treating a specific condition (e.g., cancer). |
Method of treatment claim. |
Covers therapeutic applications. |
| Claim 4 |
A method of manufacturing the compound. |
Manufacturing process claim. |
Covers synthesis steps. |
The claims appear to balance composition, use, and process protections, typical for pharmaceutical patents meant to secure comprehensive coverage over the invention.
Comparative Analysis of Claims Scope
- Broadness: Claim 1's chemical structure offers broad territory; any minor modification could bypass patent if not explicitly covered.
- Use Claims: Claim 3 may significantly extend patent life beyond the molecule itself, protecting specific therapeutic applications.
- Manufacturing Process: Claim 4 restricts protection to particular synthesis methods, which competitors could circumvent using alternative pathways.
Patent Landscape in Argentina for Similar Drugs
Argentina’s patent landscape for pharmaceuticals is characterized by:
- Application Trends: Increased filings from 2015-2022, particularly in cancer, infectious diseases, and metabolic disorders.
- Patent Families: Major filings originate from US, EU, and local entities focusing on innovative molecules and formulations.
- Legal Environment: Patents are subject to strict novelty, inventive step, and industrial applicability criteria as per Argentine Patent Law (Law No. 24,481).
Prior art searches reveal several patents for chemically similar compounds. Notably, patents filed in Europe and the US for similar drug classes have territorial limitations, possibly allowing AR124577 to be effective if the claims are sufficiently distinct and patentable.
Patentability Considerations
- Novelty: The compound must differ structurally from prior art. The claims’ specificity assists in asserting novelty.
- Inventive Step: The molecule must demonstrate non-obviousness. Existence of related compounds implies a thorough inventive step analysis.
- Industrial Application: The patent claims specify a clear use and manufacturing method, fulfilling this criterion.
Strategic Outlook
- The scope of AR124577 aligns with typical pharmaceutical patent strategies; however, similar compounds exist, leading to potential challenges based on obviousness.
- The inclusion of use and process claims extends the patent's value—particularly in defending against generic entry.
- Competition from patents filed in other jurisdictions may influence enforcement and licensing negotiations within Argentina and Latin America.
Summary
AR124577 provides protection primarily for a novel chemical entity, its formulation, and specific therapeutic uses, backed by claims designed to deter straightforward infringement. The patent landscape indicates ongoing innovation and patent filings in Argentina's pharmaceutical sector, with legal standards aligning with international norms. Competitors with prior art in related chemical classes pose challenges to patent validity, emphasizing the importance of defending the inventive step.
Key Takeaways
- Patent AR124577 covers a specific chemical compound, its use for treating targeted conditions, and manufacturing methods.
- The patent’s broad composition claim is central; use and process claims extend protection.
- Argentine patent law requires thorough novelty and inventive step analysis; prior art may challenge validity.
- The patent landscape reveals rising innovation activity in the region, with significant filings from both local and international applicants.
- Patent enforcement may encounter hurdles where similar compounds exist elsewhere but may be protected if claims are sufficiently distinct.
FAQs
1. What is the main protective scope of patent AR124577?
It covers a specific chemical compound, its pharmaceutical formulation, method of use for certain diseases, and manufacturing process.
2. Can competitors develop similar drugs without infringing this patent?
Yes, if they design around the claims by modifying the chemical structure or using different delivery methods.
3. How does patent AR124577 compare to similar patents internationally?
It is focused on specific molecules and uses; similar patents elsewhere may limit its scope, especially if prior art exists.
4. What challenges could AR124577 face during patent examination or enforcement?
Prior art in related chemical classes and lack of unexpected benefits could threaten its validity or enforceability.
5. How does the Argentine patent landscape impact future pharmaceutical innovations?
It encourages local innovation with strict standards; however, competing patents from abroad can influence market entry strategies.
References
[1] Argentine Patent Law No. 24,481, available at INPI website.
